Isn’t Robert Kiyosaki Buying the Dip in Crypto and Gold?
As crypto and precious metals slide, investors eye Robert Kiyosaki’s stance. He emphasizes context over price, signal...
Which Credit Card Has The Best Travel Rewards
Choosing the right credit card for travel rewards can be challenging. Find out which options provide the best benefits for you.
27,921 articles
Adobe Down 2026: Should Investors Switch to Alphabet?
Adobe has fallen sharply in 2026, prompting a rotation debate toward Alphabet as AI momentum and big-cap investments ...
Cramer Says Chair Won’t Spark Markets at Debut This Week
As a new Federal Reserve chair makes his debut, Jim Cramer argues markets should expect stability, not shocks. Trader...
It's Gambling: Warren Buffett Warns Investors Today
Warren Buffett’s blunt warning that today’s market mood resembles gambling hits a nerve with everyday investors. This...
The Digital Gold Narrative Fails Bitcoin Again in 2026
Bitcoin faces renewed scrutiny as gold climbs and crypto markets wobble in early 2026, challenging the widely watched...
Larry Coben Rides Power Wave to S&P's Top Stock Spotlight
NRG Energy surges to the lead in 2025, driven by Larry Coben’s leadership and a strategy to pair robust gas-fired gen...
Howard Marks Makes Degree Turn on AI After Claude Tutorial
Howard Marks has publicly shifted his stance on AI after a Claude tutorial, urging investors to balance opportunity w...
DeFi Needs a Metric Protected to Gauge Capital Resilience
DeFi is at a crossroads: grow or endure risk. Experts propose a defended capital metric to measure true resilience be...
Hedge Fund Manager Admits I Can’t Invest Like Buffett Anymore
A hedge fund manager publicly admits that his temperament blocks Buffett-style value investing. The admission highlig...
Forget Palantir: Unstoppable AI Stocks to Buy Right Now
As Palantir hype cools, two AI-driven cash-flow engines emerge as steadier bets. This report explains why Alphabet an...
China Against Everybody: The New Geopolitics of Rare Earths
Investors watch a sharpened geopolitical debate over rare earths as China tightens grip on key materials and the US a...
Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status